Breaking News Instant updates and real-time market news.

2020-11-30 07:45:00 BIIB Biogen $243.90 / +1.85 (+0.76%) , SAGE Sage Therapeutics $76.04 / -6.57 (-7.95%) 07:45 11/30/20 11/30 07:45 11/30/20 07:45	Sage Therapeutics to hold a business news update conference call Sage Therapeutics discusses the global collaboration with Biogen to jointly develop and commercialize potential breakthrough therapies in depression and movement disorders on a conference call to be held on November 30 at 8 am. Webcast Link BIIB Biogen $243.90 / +1.85 (+0.76%) SAGE Sage Therapeutics $76.04 / -6.57 (-7.95%)	30 Nov 30 Nov 07 Mar
BIIB SAGE BIIB Biogen $243.90 / +1.85 (+0.76%) 11/27/20 Stifel Stifel says license deal 'good' for Biogen, takes some upside off table for Sage 11/10/20 Truist Truist raises Biogen price target to $443, views aducanumab approval as 'likely' 11/10/20 DZ Bank Biogen upgraded to Buy from Hold at DZ Bank 11/09/20 BMO Capital Biogen price target lowered to $253 from $343 at BMO Capital SAGE Sage Therapeutics $76.04 / -6.57 (-7.95%) 11/19/20 Oppenheimer Sage Therapeutics price target raised to $94 from $65 at Oppenheimer 11/16/20 Fly Intel: Top five analyst downgrades 11/16/20 Morgan Stanley Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations

2020-11-30 07:45:00

BIIB

Biogen

$243.90 / +1.85 (+0.76%)

, SAGE

Sage Therapeutics

$76.04 / -6.57 (-7.95%)

07:45

11/30/20

11/30

07:45

11/30/20

07:45

Sage Therapeutics to hold a business news update conference call

Sage Therapeutics discusses the global collaboration with Biogen to jointly develop and commercialize potential breakthrough therapies in depression and movement disorders on a conference call to be held on November 30 at 8 am. Webcast Link

BIIB

Biogen

$243.90 / +1.85 (+0.76%)

SAGE

Sage Therapeutics

$76.04 / -6.57 (-7.95%)

30
Nov
30
Nov
07
Mar

BIIB
SAGE

BIIB Biogen

$243.90 / +1.85 (+0.76%)

11/27/20 Stifel: Stifel says license deal 'good' for Biogen, takes some upside off table for Sage

11/10/20 Truist: Truist raises Biogen price target to $443, views aducanumab approval as 'likely'

11/10/20 DZ Bank: Biogen upgraded to Buy from Hold at DZ Bank

11/09/20 BMO Capital: Biogen price target lowered to $253 from $343 at BMO Capital

SAGE Sage Therapeutics

$76.04 / -6.57 (-7.95%)

11/19/20 Oppenheimer: Sage Therapeutics price target raised to $94 from $65 at Oppenheimer

11/16/20: Fly Intel: Top five analyst downgrades

11/16/20 Morgan Stanley: Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations

TODAY'S FREE FLY STORIES

Hot Stocks	Myovant Sciences, Pfizer report 'positive' results from Phase 3 SPIRIT study » 06:56 01/26/21 01/26 06:56 01/26/21 06:56 MYOV Myovant Sciences $20.73 / -0.16 (-0.77%) , PFE Pfizer $37.28 / +0.74 (+2.03%) Myovant Sciences (MYOV)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MYOV PFE MYOV Myovant Sciences $20.73 / -0.16 (-0.77%) 01/20/21 Myovant Sciences announces employment inducement grants 01/05/21 Myovant Sciences announces distribution of ORGOVYX in the U.S. 01/04/21 Myovant Sciences names David Marek as CEO, succeeding Lynn Seely 12/28/20 Myovant Sciences rises 26.0% PFE Pfizer $37.28 / +0.74 (+2.03%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 Pfizer, Merck KGaA announce EC approval of Bavencio for UC patients 01/22/21 Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine 01/22/21 Coty promotes Stephane Delbos to chief procurement officer MYOV PFE MYOV Myovant Sciences $20.73 / -0.16 (-0.77%) 01/08/21 SVB Leerink Myovant Sciences downgraded to Market Perform from Outperform at SVB Leerink 01/06/21 Goldman Sachs Myovant Sciences downgraded to Neutral from Buy at Goldman Sachs 12/29/20 Citi Citi boosts Myovant target to $30 on 'smart deal' with Pfizer 12/29/20 Baird Baird positive on Myovant Sciences deal announcement with Pfizer PFE Pfizer $37.28 / +0.74 (+2.03%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg MYOV PFE MYOV Myovant Sciences $20.73 / -0.16 (-0.77%) 11/12/20 Myovant Sciences reports Q2 EPS (75c), consensus (73c) 08/11/20 Myovant Sciences reports Q1 EPS (37c), consensus (68c) PFE Pfizer $37.28 / +0.74 (+2.03%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 PFE PFE Pfizer $37.28 / +0.74 (+2.03%) 01/25/21 Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says 01/25/21 Pfizer to ship fewer vaccine vials to fulfill commitment to U.S., NY Times says 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says MYOV PFE MYOV Myovant Sciences $20.73 / -0.16 (-0.77%) 12/28/20 Fly Intel: Wall Street's top stories for Monday 12/28/20 Fly Intel: Wall Street's top stories at midday 12/28/20 Fly Intel: Pre-market Movers 09/29/20 Fly Intel: Wall Street's top stories for Tuesday PFE Pfizer $37.28 / +0.74 (+2.03%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 02/02/21 Pfizer - PFE 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE PFE Pfizer $37.28 / +0.74 (+2.03%) 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th
Upgrade	Dollar General upgraded to Buy from Hold at Loop Capital » 06:56 01/26/21 01/26 06:56 01/26/21 06:56 DG Dollar General $206.42 / +0.08 (+0.04%) Loop Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options DG Dollar General $206.42 / +0.08 (+0.04%) 01/13/21 Dollar General to offer pay to employees to get COVID-19 vaccine 12/03/20 Dollar General reports Q3 gross profit as a percentage of net sales of 31.3% 12/03/20 Dollar General reports total merchandise inventories, at cost, $5B at October 30 12/03/20 Dollar General provides FY21 store growth outlook DG Dollar General $206.42 / +0.08 (+0.04%) 05:45 Today Loop Capital Dollar General upgraded to Buy from Hold at Loop Capital 12/04/20 Loop Capital Dollar General price target raised to $220 from $210 at Loop Capital 12/04/20 BMO Capital Dollar General price target raised to $240 from $223 at BMO Capital 12/04/20 Citi Dollar General price target raised to $250 from $235 at Citi DG Dollar General $206.42 / +0.08 (+0.04%) 12/03/20 Dollar General not issuing updated FY20 sales, EPS guidance 12/03/20 Dollar General reports Q3 EPS $2.31, consensus $2.00 12/02/20 Notable companies reporting before tomorrow's open 12/02/20 Notable companies reporting before tomorrow's open DG Dollar General $206.42 / +0.08 (+0.04%) 12/03/20 Fly Intel: Pre-market Movers 10/09/20 SpartanNash spikes after granting Amazon option to buy stake 08/27/20 Fly Intel: Wall Street's top stories for Thursday 08/27/20 Fly Intel: Wall Street's top stories at midday DG Dollar General $206.42 / +0.08 (+0.04%) 12/28/20 Dollar General put volume heavy and directionally bearish 12/03/20 Unusually active option classes on open December 3rd
Hot Stocks	Comscore announces partnership agreement with Strong Automotive Merchandising » 06:55 01/26/21 01/26 06:55 01/26/21 06:55 SCOR Comscore $3.40 / -0.03 (-0.87%) Comscore announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SCOR Comscore $3.40 / -0.03 (-0.87%) 01/11/21 Comscore, others launch cookie-free audience targeting solution 01/07/21 Comscore announces strategic investment by Charter, Qurate Retail, Cerberus 12/11/20 Comscore in advanced talks for convertible preferred stock deal with investor 12/10/20 Comscore announces renewal agreement with Tegna, to include 22 markets SCOR Comscore $3.40 / -0.03 (-0.87%) 01/11/21 Loop Capital Comscore upgraded to Buy from Hold at Loop Capital 01/11/21 Loop Capital Comscore upgraded to Buy from Hold at Loop Capital 08/19/20 Truist Comscore most likely to remain independent, says Truist SCOR Comscore $3.40 / -0.03 (-0.87%) 11/09/20 Comscore reports Q3 EPS (16c), consensus (19c) 08/10/20 Comscore reports Q2 EPS (15c), consensus (26c) SCOR Comscore $3.40 / -0.03 (-0.87%) 01/07/21 Comscore near financing deal with Charter, Qurate and Cerberus, WSJ says 01/07/21 Comscore near financing deal with Charter, Qurate and Cerberus, WSJ says SCOR Comscore $3.40 / -0.03 (-0.87%) 11/09/20 Fly Intel: After-Hours Movers 08/10/20 Fly Intel: After-Hours Movers
Recommendations	Square short- and long-term setup 'remains impressive,' says Barclays » 06:55 01/26/21 01/26 06:55 01/26/21 06:55 SQ Square / + Square's mobile app… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SQ Square / + 01/04/21 Square says FinCEN proposed rules create 'unnecessary friction,' less visibility 11/25/20 Square acquires Credit Karma Tax for $50M in cash 11/25/20 Intuit gets DOJ nod to buy Credit Karma after pact to sell tax unit to Square 11/25/20 Intuit reports Credit Karma Tax business to be sold to Square SQ Square / + 01/14/21 Evercore ISI Square price target raised to $304 on Cash App strength at Evercore ISI 01/07/21 Mizuho Rising bitcoin prices 'boon' to Square revenue, says Mizuho 01/06/21 Truist Square price target raised to $300 from $250 at Truist 12/24/20 Stephens Stephens says Tidal deal would show Square 'ambition' beyond most expectations SQ Square / + 11/05/20 Square reports Q3 adjusted EPS 34c, consensus 16c 11/05/20 Square reports Q3 revenue $3.03B, consensus $2.07B 11/05/20 Notable companies reporting after market close 08/04/20 Square reports Q2 adjusted EPS 18c, consensus (5c) SQ Square / + 12/24/20 Square held talks to acquire music service Tidal, Bloomberg reports 11/25/20 DOJ wants Intuit to sell Credit Karma tax unit to approve deal, CNBC says 11/18/20 Google to offer checking accounts as part of pay app update, CNBC reports 10/30/20 Square in talks to buy tax-prep business of Credit Karma, WSJ says SQ Square / + 01/08/21 The Intersection: Crypto and Wall Street This Week 12/24/20 Fly Intel: Wall Street's top stories for Thursday 12/24/20 Fly Intel: Pre-market Movers 11/25/20 Fly Intel: Wall Street's top stories for Wednesday SQ Square / + 12/22/20 Unusual call flow in option market yesterday 12/21/20 Upside call seller takes advantage of all-time high in Square 11/09/20 Square call volume above normal and directionally bullish 10/06/20 Unusual call flow in option market yesterday
Upgrade	Comcast upgraded to Buy from Hold at TD Securities » 06:55 01/26/21 01/26 06:55 01/26/21 06:55 CMCSA Comcast $48.98 / +0.35 (+0.72%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/25/21 WWE, Peacock announce multi-year streaming agreement 01/19/21 Netflix says past year 'testament' to company's approach 01/07/21 Comscore announces strategic investment by Charter, Qurate Retail, Cerberus 01/07/21 NBCUniversal, Charter announce multi-year distribution agreement CMCSA Comcast $48.98 / +0.35 (+0.72%) 06:52 Today TD Securities Comcast upgraded to Buy from Hold at TD Securities 01/19/21 Barclays Comcast price target raised to $53 from $48 at Barclays 01/14/21 Macquarie Comcast price target raised to $58 from $53 at Macquarie 12/16/20 Morgan Stanley Morgan Stanley names Comcast a top pick, raises price target to $62 CMCSA Comcast $48.98 / +0.35 (+0.72%) 10/29/20 Comcast reports Q3 adj. EPS 65c, consensus 52c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Comcast reports Q2 adjusted EPS 69c, consensus 55c CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/22/21 Comcast to shut down sports network NBCSN by end of year, WSJ reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/13/21 Amazon plans bid for Italy's 'top soccer TV rights,' Bloomberg says 12/19/20 Comcast well positioned for post-COVID world, Barron's says CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/19/21 Fly Intel: What to watch in Netflix earnings report 12/10/20 Fly Intel: Wall Street's top stories for Thursday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 01/28/21 Comcast - CMCSA CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/11/21 Comcast put volume heavy and directionally bearish 12/24/20 Unusual call flow in option market yesterday 12/23/20 $2M block of Comcast calls tied to hedge possible stock replacement trade 12/22/20 Unusually active option classes on open December 22nd

General news	FX Update: The dollar rose and then ebbed » 06:55 01/26/21 01/26 06:55 01/26/21 06:55 FX Update: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Eli Lilly announces BLAZE-1 trial meets primary endpoint » 06:54 01/26/21 01/26 06:54 01/26/21 06:54 LLY Eli Lilly $212.52 / +6.22 (+3.02%) Bamlanivimab 2800 mg and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/22/21 Eli Lilly completes acquisition of Prevail Therapeutics 01/21/21 AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks 01/21/21 Eli Lilly: LY-CoV555 prevented Covid-19 at nursing homes in Blaze-2 trial 01/19/21 Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 Mizuho Eli Lilly upgraded to Buy from Neutral at Mizuho LLY Eli Lilly $212.52 / +6.22 (+3.02%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 LLY Eli Lilly $212.52 / +6.22 (+3.02%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Upgrade	Comcast upgraded to Buy from Hold at TD Securities » 06:52 01/26/21 01/26 06:52 01/26/21 06:52 CMCSA Comcast $48.98 / +0.35 (+0.72%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/25/21 WWE, Peacock announce multi-year streaming agreement 01/19/21 Netflix says past year 'testament' to company's approach 01/07/21 Comscore announces strategic investment by Charter, Qurate Retail, Cerberus 01/07/21 NBCUniversal, Charter announce multi-year distribution agreement CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/19/21 Barclays Comcast price target raised to $53 from $48 at Barclays 01/14/21 Macquarie Comcast price target raised to $58 from $53 at Macquarie 12/16/20 Morgan Stanley Morgan Stanley names Comcast a top pick, raises price target to $62 11/25/20 TD Securities Comcast downgraded to Hold after recent rally at TD Securities CMCSA Comcast $48.98 / +0.35 (+0.72%) 10/29/20 Comcast reports Q3 adj. EPS 65c, consensus 52c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Comcast reports Q2 adjusted EPS 69c, consensus 55c CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/22/21 Comcast to shut down sports network NBCSN by end of year, WSJ reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/13/21 Amazon plans bid for Italy's 'top soccer TV rights,' Bloomberg says 12/19/20 Comcast well positioned for post-COVID world, Barron's says CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/19/21 Fly Intel: What to watch in Netflix earnings report 12/10/20 Fly Intel: Wall Street's top stories for Thursday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 01/28/21 Comcast - CMCSA CMCSA Comcast $48.98 / +0.35 (+0.72%) 01/11/21 Comcast put volume heavy and directionally bearish 12/24/20 Unusual call flow in option market yesterday 12/23/20 $2M block of Comcast calls tied to hedge possible stock replacement trade 12/22/20 Unusually active option classes on open December 22nd
Recommendations	Macom price target raised to $65 from $52 at Barclays » 06:52 01/26/21 01/26 06:52 01/26/21 06:52 MTSI Macom / + Barclays analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MTSI Macom / + 01/25/21 Macom, AFRL enter into R&D agreement 11/12/20 Macom chairman sells 93.7K shares of common stock MTSI Macom / + 01/13/21 Piper Sandler Macom price target raised to $70 from $60 at Piper Sandler 01/13/21 Piper Sandler AMD price target raised to $110 from $100 at Piper Sandler 01/11/21 BofA Macom upgraded to Buy from Underperform at BofA 12/18/20 Piper Sandler Piper boosts Macom target to $60, calls top small pick for 2021 MTSI Macom / + 11/05/20 Macom sees Q1 adjusted EPS 41c-45c, consensus 37c 11/05/20 Macom reports Q4 adjusted EPS 40c, consensus 38c 07/29/20 Macom sees Q4 EPS 36c-40c, consensus 22c 07/29/20 Macom reports Q3 EPS 33c, consensus 21c MTSI Macom / + 07/29/20 Fly Intel: After-Hours Movers 01/28/21 Macom - MTSI 03/04/21 MACOM Technology Solutions Holdings, Inc.
Downgrade	Morgan Stanley downgrades Hamilton Lane to Equal Weight following outperformance » 06:52 01/26/21 01/26 06:52 01/26/21 06:52 HLNE Hamilton Lane / + As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events HLNE Hamilton Lane / + 01/07/21 Hamilton Lane launches fund to expand access to private markets HLNE Hamilton Lane / + 05:32 Today Morgan Stanley Hamilton Lane downgraded to Equal Weight from Overweight at Morgan Stanley 01/11/21 Wells Fargo Hamilton Lane price target raised to $77 from $70 at Wells Fargo 12/16/20 UBS Hamilton Lane initiated with a Buy at UBS 09/17/20 Morgan Stanley Hamilton Lane's recent selloff presents buying opportunity, says Morgan Stanley HLNE Hamilton Lane / + 11/04/20 Hamilton Lane reports Q2 EPS 66c, consensus 60c 08/04/20 Hamilton Lane reports Q1 EPS 11c, consensus 26c 02 Sep 03 Jun 02/24/21 22nd Annual Virtual Financial Services Forum 02/02/21 Hamilton Lane - HLNE

Recommendations	Veeco price target raised to $22 from $15 at Barclays » 06:51 01/26/21 01/26 06:51 01/26/21 06:51 VECO Veeco $20.53 / -0.14 (-0.68%) Barclays analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VECO Veeco $20.53 / -0.14 (-0.68%) 10/20/20 Aledia selects Veeco's 300mm MOCVD Platform 10/14/20 A-Pro Semicon chooses Veeco's Propel HVM MOCVD platform 08/12/20 IHP Microelectronics selects Veeco MOCVD platform for communication applications VECO Veeco $20.53 / -0.14 (-0.68%) 12/29/20 Goldman Sachs Veeco price target raised to $18 from $16 at Goldman Sachs 09/17/20 Barclays Veeco initiated with an Overweight at Barclays 09/15/20 Goldman Sachs Veeco upgraded to Buy from Neutral at Goldman Sachs 09/09/20 Stifel Veeco selloff overdone given limited semi exposure in China, says Stifel VECO Veeco $20.53 / -0.14 (-0.68%) 10/27/20 Veeco sees Q4 EPS 22c-37c, consensus 26c 10/27/20 Veeco reports Q3 EPS 22c, consensus 20c 08/03/20 Veeco sees Q3 EPS 10c-26c, consensus 16c 08/03/20 Veeco reports Q2 EPS 11c, consensus 7c VECO Veeco $20.53 / -0.14 (-0.68%) 08/03/20 Fly Intel: After-Hours Movers 02/11/21 Veeco - VECO
Recommendations	Texas Instruments price target raised to $155 from $140 at Barclays » 06:51 01/26/21 01/26 06:51 01/26/21 06:51 TXN Texas Instruments / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TXN Texas Instruments / + 12/09/20 Texas Instruments: Most of HiRel semiconductor products now available online 11/18/20 Xilinx works with Texas Instruments to develop DFE radio application solutions 10/20/20 Texas Instruments CEO says notable strength from rebound of automotive demand 09/21/20 Amazon Sidewalk working with Semtech, Silicon Labs and TI on new IoT chipsets TXN Texas Instruments / + 01/21/21 Oppenheimer Texas Instruments price target raised to $185 from $180 at Oppenheimer 01/21/21 Oppenheimer Texas Instruments price target raised to $185 from $180 at Oppenheimer 12/17/20 Deutsche Bank Texas Instruments price target raised to $150 from $145 at Deutsche Bank 12/16/20 Citi Citi sees 'substantial upside' to semi estimates after latest checks TXN Texas Instruments / + 10/20/20 Texas Instruments sees Q4 EPS $1.20-$1.40, consensus $1.19 10/20/20 Texas Instruments reports Q3 EPS $1.45, consensus $1.27 10/20/20 Notable companies reporting after market close TXN Texas Instruments / + 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/22/20 'Underappreciated' Synaptics shares have more upside, Barron's says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says TXN Texas Instruments / + 10/20/20 Fly Intel: After-Hours Movers 16:30 Today Texas Instruments - TXN TXN Texas Instruments / + 12/28/20 Texas Instruments put volume heavy and directionally bearish 12/21/20 Texas Instruments put volume heavy and directionally bearish 11/10/20 Texas Instruments put volume heavy and directionally bearish 10/30/20 Texas Instruments put volume heavy and directionally bearish
Hot Stocks	Rockwell Automation names Scott Genereux as chief revenue officer » 06:51 01/26/21 01/26 06:51 01/26/21 06:51 ROK Rockwell Automation $260.62 / -5.29 (-1.99%) Rockwell Automation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ROK Rockwell Automation $260.62 / -5.29 (-1.99%) 11/20/20 Rockwell Automation's Fooks sells 7,000 common shares 11/17/20 Rockwell Automation CEO: Fiix is a really exciting acquisition for us 11/17/20 Rockwell Automation to buy AI-enabled CMMS company. Fiix 11/04/20 Rockwell Automation raises quarterly dividend to $1.07 per share ROK Rockwell Automation $260.62 / -5.29 (-1.99%) 01/04/21 Vertical Research Rockwell Automation upgraded to Hold from Sell at Vertical Research 11/30/20 Barclays Rockwell Automation downgraded to Equal Weight on valuation at Barclays 11/30/20 Barclays Rockwell Automation downgraded to Equal Weight from Overweight at Barclays 11/23/20 Fly Intel: Top five analyst upgrades ROK Rockwell Automation $260.62 / -5.29 (-1.99%) 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 11/10/20 Rockwell Automation sees FY21 adj. EPS $8.45-$8.85, consensus $7.99 11/10/20 Rockwell Automation reports Q4 adj. EPS $1.87, consensus $1.76 08:30 Today Rockwell Automation - ROK 02/02/21 Rockwell Automation Inc
Recommendations	Skyworks price target raised to $165 from $150 at Barclays » 06:51 01/26/21 01/26 06:51 01/26/21 06:51 SWKS Skyworks / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SWKS Skyworks / + 01/13/21 Skyworks announces milestone in SKY66318-21 power amplifier shipments 11/02/20 Skyworks up 1% to $144.00 after Q4 earnings beat SWKS Skyworks / + 01/25/21 Citi Skyworks price target raised to $164 from $137 at Citi 01/11/21 BofA Skyworks downgraded to Neutral from Buy at BofA 01/06/21 KeyBanc Skyworks price target raised to $180 from $170 at KeyBanc 12/14/20 Goldman Sachs Skyworks price target raised to $171 from $162 SWKS Skyworks / + 11/02/20 Skyworks sees Q1 EPS $2.06 at midpoint of revenue view, consensus $1.80 11/02/20 Skyworks reports Q4 EPS $1.85, consensus $1.52 11/02/20 Notable companies reporting after market close SWKS Skyworks / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/02/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 01/28/21 Skyworks - SWKS SWKS Skyworks / + 12/15/20 Early notable gainers among liquid option names on December 15th 12/04/20 Skyworks call volume above normal and directionally bullish 11/30/20 Skyworks call volume above normal and directionally bullish 11/25/20 Skyworks put volume heavy and directionally bearish
Recommendations	SiTime price target raised to $150 from $100 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 SITM SiTime / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SITM SiTime / + 12/15/20 SiTime announces 2B units of silicon MEMS timing solutions shipped 12/01/20 SiTime CFO sells 25K shares of common stock 09/18/20 SiTime CEO sells 30K shares of common stock 08/06/20 SiTime sees 'good chance' of additional revenue in Q3 from phone design win SITM SiTime / + 12/30/20 Roth Capital SiTime price target raised to $130 from $110 at Roth Capital 11/25/20 Lynx SiTime benefiting from October fire at AKM factory in Japan, says Lynx 11/05/20 Needham SiTime price target raised to $105 from $75 at Needham 10/15/20 Roth Capital SiTime price target raised to $110 from $80 at Roth Capital SITM SiTime / + 11/24/20 SiTime sees Q4 revenue up 10%-15% sequentially 11/04/20 SiTime reports Q3 EPS 23c, consensus 15c 08/31/20 SiTime raises Q3 revenue view from $28M-$29M to $31M-$32M, consensus $28.53M 08/05/20 SiTime reports Q2 EPS (14c), consensus (21c) 12 Jun SITM SiTime / + 08/31/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 02/03/21 SiTime - SITM

Recommendations	Silicon Labs price target raised to $150 from $135 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 SLAB Silicon Labs / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SLAB Silicon Labs / + 10/21/20 Silicon Labs and Teledyne e2v HiRel partner on high reliability isolation 09/29/20 Silicon Labs promotes Serena Townsend to vice president and Chief People Officer 09/21/20 Amazon Sidewalk working with Semtech, Silicon Labs and TI on new IoT chipsets 09/21/20 Silicon Labs, Amazon.com collaborate on Sidewalk SLAB Silicon Labs / + 01/25/21 Citi Silicon Labs price target raised to $165 from $121 at Citi 01/19/21 Fly Intel: Top five analyst initiations 01/19/21 Morgan Stanley Silicon Labs initiated with an Equal Weight at Morgan Stanley 12/30/20 Roth Capital Silicon Labs price target raised to $140 from $120 at Roth Capital SLAB Silicon Labs / + 10/28/20 Silicon Labs sees Q4 adjusted EPS 68c-78c, consensus 71c 10/28/20 Silicon Labs reports Q3 adjusted EPS 73c, consensus 73c 07/29/20 Silicon Labs sees Q3 adjusted EPS 67c-77c, consensus 64c 07/29/20 Silicon Labs reports Q2 adjusted EPS 74c, consensus 57c 02/03/21 Silicon Labs - SLAB
Recommendations	Qualcomm price target raised to $150 from $135 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 QCOM Qualcomm / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options QCOM Qualcomm / + 05:29 Today Veoneer, Qualcomm to collaborate on scalable ADAS/AD solutions 01/13/21 Qualcomm to acquire NUVIA for approximately $1.4B 01/13/21 Qualcomm to acquire NUVIA for approximately $1.4B 01/05/21 Qualcomm's Mollenkopf says 'right time' for Cristiano Amon to assume leadership QCOM Qualcomm / + 01/06/21 KeyBanc Skyworks price target raised to $180 from $170 at KeyBanc 01/06/21 KeyBanc Qualcomm price target raised to $180 from $175 at KeyBanc 01/05/21 Wells Fargo Wells Fargo sees 'seamless transition' for new Qualcomm CEO 01/05/21 Canaccord Qualcomm price target raised to $180 from $175 at Canaccord QCOM Qualcomm / + 11/04/20 Qualcomm sees Q1 adjusted EPS $1.95-$2.15, consensus $1.68 11/04/20 Qualcomm reports Q4 adjusted EPS $1.45, consensus $1.17 11/04/20 Notable companies reporting after market close 07/29/20 Qualcomm sees Q4 EPS $1.05-$1.25, consensus $1.10 QCOM Qualcomm / + 01/21/21 Qualcomm rolls out Snapdragon 870 series, DigiTimes reports 12/11/20 Apple begins work on own cellular modem, Bloomberg reports 12/09/20 Qualcomm to post 'strong' earnings, gross margins in 2021, DigiTimes reports 12/03/20 Samsung cuts foundry quotes for 5nm chip orders, DigiTimes reports QCOM Qualcomm / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 02/11/21 Technology & Internet Virtual Conference 02/03/21 Qualcomm - QCOM 03/10/21 Qualcomm Inc. QCOM Qualcomm / + 12/07/20 Qualcomm call buyer realizes 32% same-day gains 12/04/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Early notable gainers among liquid option names on November 11th
Recommendations	Qorvo price target raised to $185 from $160 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 QRVO Qorvo / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options QRVO Qorvo / + 01/11/21 Qorvo launches automotive eCall Switch 12/07/20 Poet Technologies appoints Glen Riley to board of directors 11/13/20 Zomedica expects to begin commercialization of TRUFORMA on March 30, 2021 11/05/20 Qorvo wins U.S. government project to create RF semiconductor packaging center QRVO Qorvo / + 01/25/21 Citi Qorvo price target raised to $188 from $144 at Citi 12/28/20 Mizuho Qorvo price target raised to $180 from $155 at Mizuho 12/22/20 Benchmark Qorvo price target raised to $185 from $155 at Benchmark 12/14/20 Goldman Sachs Qorvo price target raised to $190 from $180 at Goldman Sachs QRVO Qorvo / + 11/04/20 Qorvo sees Q4 non-GAAP EPS $2.65, consensus $1.90 11/04/20 Qorvo reports Q2 non-GAAP EPS $2.43, consensus $2.12 11/04/20 Notable companies reporting after market close 09/08/20 Qorvo raises Q2 EPS view to $2.14 from $1.90, consensus $1.91 QRVO Qorvo / + 09/08/20 Fly Intel: After-Hours Movers 07/30/20 Walmart, Target initiations among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 02/03/21 Qorvo - QRVO QRVO Qorvo / + 01/21/21 Unusually active option classes on open January 21st 12/15/20 Early notable gainers among liquid option names on December 15th 11/30/20 Early notable gainers among liquid option names on November 30th 11/11/20 Early notable gainers among liquid option names on November 11th
Earnings	Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) Consensus $8.99. Sees… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:49 Today Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Addex Therapeutics receives IND approval to start study in epilepsy JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:46 Today Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 03/01/21 41st Annual Healthcare Virtual Conference 08:30 Today Johnson & Johnson - JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Recommendations	NXP Semiconductors price target raised to $200 from $150 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 NXPI NXP Semiconductors / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NXPI NXP Semiconductors / + 12/09/20 NXP Semiconductors' Owen sells over 7,000 common shares 12/02/20 NXP Semiconductors reports availability of 2nd genreation RF multichip modules 11/25/20 NXP Semiconductors CEO sells 10K shares of common stock 11/25/20 NXP Semiconductors chairman sells 12K shares of common stock NXPI NXP Semiconductors / + 01/15/21 Truist NXP Semiconductors price target raised to $209 from $165 at Truist 01/06/21 KeyBanc NXP Semiconductors price target raised to $195 from $190 at KeyBanc 12/28/20 Mizuho NXP Semiconductors price target raised to $173 from $155 at Mizuho 12/17/20 KeyBanc NXP Semiconductors price target raised to $190 from $160 at KeyBanc NXPI NXP Semiconductors / + 10/26/20 NXP Semiconductors reports Q3 EPS (8c) vs. 38c a year ago 10/26/20 NXP Semiconductors sees Q4 adjusted operating income $692M-$766M 10/26/20 NXP Semiconductors reports Q3 adj. operating income $586M vs. $687M a year ago 10/26/20 NXP Semiconductors sees Q4 revenue $2.38B-$2.53B, consensus $2.27B NXPI NXP Semiconductors / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 10/26/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Wall Street's top stories for Friday 02/02/21 NXP Semiconductors - NXPI NXPI NXP Semiconductors / + 10/01/20 NXP Semiconductors put volume heavy and directionally bearish 09/08/20 NXP Semiconductors put volume heavy and directionally bearish 09/04/20 NXP Semiconductors put volume heavy and directionally bearish 08/27/20 NXP Semiconductors call volume above normal and directionally bullish

Hot Stocks	Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 GMAB Genmab $42.68 / -0.41 (-0.95%) , JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) Genmab (GMAB) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GMAB JNJ GMAB Genmab $42.68 / -0.41 (-0.95%) 01/15/21 Genmab says Janssen granted FDA approval for Darzalez Faspro 01/13/21 Genmab achieves $40M milestone in AbbVie collaboration 01/04/21 Genmab announces initiation of innovaTV 301 trial 11/24/20 Genmab will not advance development of enapotamab vedotin after POC data JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Addex Therapeutics receives IND approval to start study in epilepsy 01/19/21 Royalty Pharma acquires royalty interest in Seltorexant from Minerva GMAB JNJ GMAB Genmab $42.68 / -0.41 (-0.95%) 01/25/21 DNB Markets Genmab downgraded to Sell from Hold at DNB Markets 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight on valuation at Morgan Stanley 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight from Overweight at Morgan Stanley 01/15/21 H.C. Wainwright Genmab price target raised to $49 from $44 at H.C. Wainwright JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:46 Today Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 03/01/21 41st Annual Healthcare Virtual Conference 08:30 Today Johnson & Johnson - JNJ JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Recommendations	Nvidia price target raised to $600 from $550 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 NVDA Nvidia / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia / + 01/17/21 Fly Intel: Top five weekend stock stories 01/10/21 Fly Intel: Top five weekend stock stories 01/10/21 Nio partners with Nvidia to develop new generation of automated driving EV 01/06/21 UK's CMA to investigate NVIDIA's takeover of Arm NVDA Nvidia / + 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/15/21 Truist Nvidia price target raised to $672 from $643 at Truist 01/15/21 Susquehanna Nvidia price target raised to $625 from $610 at Susquehanna 01/12/21 Wells Fargo Nvidia very-well positioned as gaming momentum continues, says Wells Fargo NVDA Nvidia / + 11/18/20 Nvidia sees Q4 revenue $4.8B +/- 2%, consensus $4.42B 11/18/20 Nvidia reports Q3 EPS $2.91, consensus $2.57 11/18/20 Notable companies reporting after market close 08/19/20 Nvidia sees Q3 revenue $4.4B, plus or minus 2%, consensus $3.97B NVDA Nvidia / + 01/16/21 Intel rebound will still take time, Barron's says 12/20/20 Chip makers under threat from big tech companies, WSJ reports 12/11/20 Samsung seeing yield issues for 8nm process, DigiTimes reports 12/08/20 Intel, Nvidia asked about tech sale to China used against Uighurs, Reuters says NVDA Nvidia / + 01/22/21 The Intersection: Crypto and Wall Street This Week 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 01/15/21 The Intersection: Crypto and Wall Street This Week 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla NVDA Nvidia / + 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains 10/06/20 Early notable gainers among liquid option names on October 6th
Recommendations	Maxim Integrated price target raised to $95 from $74 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 MXIM Maxim Integrated / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MXIM Maxim Integrated / + 10/08/20 Analog Devices, Maxim Integrated shareholders approve merger 09/23/20 Maxim Integrated and Serial Microelectronics sign distribution agreement 07/28/20 Maxim Integrated says no dividend to be paid for next four quarters MXIM Maxim Integrated / + 01/25/21 Deutsche Bank Maxim Integrated price target raised to $101 from $95 at Deutsche Bank 12/17/20 Deutsche Bank Maxim Integrated price target raised to $95 from $90 at Deutsche Bank 11/25/20 Truist Analog Devices price target raised to $164 from $136 at Truist 08/20/20 RBC Capital Analog Devices price target raised to $135 from $130 at RBC Capital MXIM Maxim Integrated / + 10/27/20 Maxim Integrated reports Q1 EPS 72 ex-items, consensus 58c 10/27/20 Notable companies reporting after market close 07/28/20 Maxim Integrated reports Q4 adjusted EPS 58c, consensus 57c 07/28/20 Notable companies reporting after market close
Recommendations	Marvell price target raised to $60 from $50 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 MRVL Marvell / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MRVL Marvell / + 12/23/20 Marvell VP Dean Jarnac sells $576K in company shares 12/15/20 Marvell says HSR waiting period in connection with Inphi acquisition has expired 12/03/20 Marvell CEO says Q3 revenue growth driven by networking business 12/03/20 Marvell sees Q4 adjusted gross margin approximately 64% MRVL Marvell / + 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/25/21 Citi Marvell price target raised to $64 from $50 at Citi 01/15/21 Susquehanna Marvell price target raised to $60 from $54 at Susquehanna 01/13/21 Piper Sandler Marvell price target raised to $60 from $50 at Piper Sandler MRVL Marvell / + 12/03/20 Marvell sees Q4 adjusted EPS 25c-33c, consensus 29c 12/03/20 Marvell reports Q3 adjusted EPS 25c, consensus 25c 10/29/20 Marvell sees Q3 revenue $750M +/- 2%, consensus $750.97M 08/27/20 Marvell sees Q3 adjusted EPS 22c-28c, consensus 25c MRVL Marvell / + 10/29/20 Marvell near deal to acquire Inphi for about $10B, WSJ reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says MRVL Marvell / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Fly Insider:180 Degree Capital, AMC among week's notable insider trades 12/04/20 Fly Intel: Wall Street's top stories for Friday 12/04/20 Fly Intel: Wall Street's top stories at midday MRVL Marvell / + 12/21/20 Unusual call flow in option market yesterday 12/18/20 Call Seller in Marvell exits Dec trade for 97% loss 12/17/20 Marvell call volume above normal and directionally bullish 12/03/20 Marvell options imply 7.5% move in share price post-earnings
Recommendations	Lam Research price target raised to $600 from $405 at Barclays » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 LRCX Lam Research / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LRCX Lam Research / + 12/02/20 Lam Research VP Vahid Vahedi sells almost $1.3M in company shares 11/16/20 Lam Research CFO sells 8.2K shares of common stock 11/05/20 Lam Research announces $5B share repurchase authorization, quarterly dividend 08/27/20 Lam Research raises quarterly dividend 13% to $1.30 per share LRCX Lam Research / + 01/25/21 B. Riley Securities Lam Research price target raised to $650 from $600 at B. Riley Securities 01/25/21 Credit Suisse Lam Research price target raised to $650 from $450 at Credit Suisse 01/25/21 Deutsche Bank Lam Research price target raised to $575 from $500 at Deutsche Bank 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment LRCX Lam Research / + 10/21/20 Lam Research sees Q2 EPS $5.60, +/- 40c, consensus $5.16 10/21/20 Lam Research reports Q1 EPS $5.67, consensus $5.19 10/21/20 Notable companies reporting after market close 07/29/20 Lam Research sees Q3 EPS $5.15 +/- 40c, consensus $4.14 LRCX Lam Research / + 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports LRCX Lam Research / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 01/27/21 Lam Research - LRCX LRCX Lam Research / + 11/27/20 Early notable gainers among liquid option names on November 27th 10/06/20 Lam Research call volume above normal and directionally bullish 09/24/20 Early notable gainers among liquid option names on September 24th 09/02/20 Lam Research call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

ALV
Today at 08:00

Autoliv - ALV Conference Calls
XRX
Today at 08:00

Xerox - XRX Conference Calls
RYTM
Today at 08:00

Rhythm Pharmaceuticals - RYTM Conference Calls
GE
Today at 08:00

General Electric - GE Conference Calls
BRO
Today at 08:00

Brown & Brown - BRO Conference Calls
LIQT
Today at 08:00

LiqTech International, Inc. Firm Sponsored Meetings

Virtual Meeting
AGNC
Today at 08:30

AGNC Investment - AGNC Conference Calls
DHI
Today at 08:30

D.R. Horton - DHI Conference Calls
STLD
Today at 08:30

Steel Dynamics - STLD Conference Calls
RTX
Today at 08:30

Raytheon Technologies - RTX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James $2.20 QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG $2.66 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

Sage Therapeutics to hold a business news update conference call

TODAY'S FREE FLY STORIES

Get Full Fly Access